[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

DE69619860D1 - Verfahren zur herstellung aktiver substanzen aus perlmutt, resultierende produkte, geeignet für medizinische anwendungen - Google Patents

Verfahren zur herstellung aktiver substanzen aus perlmutt, resultierende produkte, geeignet für medizinische anwendungen

Info

Publication number
DE69619860D1
DE69619860D1 DE69619860T DE69619860T DE69619860D1 DE 69619860 D1 DE69619860 D1 DE 69619860D1 DE 69619860 T DE69619860 T DE 69619860T DE 69619860 T DE69619860 T DE 69619860T DE 69619860 D1 DE69619860 D1 DE 69619860D1
Authority
DE
Germany
Prior art keywords
fraction
substances
pearl
medical applications
resulting products
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69619860T
Other languages
English (en)
Other versions
DE69619860T2 (de
Inventor
Evelyne Lopez
Michel Giraud
Sophie Berland
Christian Milet
Gilles Gutierrez
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Centre National de la Recherche Scientifique CNRS
Original Assignee
Centre National de la Recherche Scientifique CNRS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Centre National de la Recherche Scientifique CNRS filed Critical Centre National de la Recherche Scientifique CNRS
Application granted granted Critical
Publication of DE69619860D1 publication Critical patent/DE69619860D1/de
Publication of DE69619860T2 publication Critical patent/DE69619860T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/56—Materials from animals other than mammals
    • A61K35/618—Molluscs, e.g. fresh-water molluscs, oysters, clams, squids, octopus, cuttlefish, snails or slugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/43504—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Epidemiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Toxicology (AREA)
  • Immunology (AREA)
  • Dermatology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Materials For Medical Uses (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DE69619860T 1995-12-28 1996-12-27 Verfahren zur herstellung aktiver substanzen aus perlmutt, resultierende produkte, geeignet für medizinische anwendungen Expired - Lifetime DE69619860T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9515650A FR2743075B1 (fr) 1995-12-28 1995-12-28 Procede de preparation de substances actives a partir de la nacre, produits obtenus, utiles notamment comme medicaments
PCT/FR1996/002098 WO1997024133A1 (fr) 1995-12-28 1996-12-27 Procede de preparation de substances actives a partir de la nacre, produits obtenus, utiles notamment comme medicaments

Publications (2)

Publication Number Publication Date
DE69619860D1 true DE69619860D1 (de) 2002-04-18
DE69619860T2 DE69619860T2 (de) 2002-11-07

Family

ID=9486075

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69619860T Expired - Lifetime DE69619860T2 (de) 1995-12-28 1996-12-27 Verfahren zur herstellung aktiver substanzen aus perlmutt, resultierende produkte, geeignet für medizinische anwendungen

Country Status (9)

Country Link
US (1) US6251438B1 (de)
EP (1) EP0869805B1 (de)
JP (1) JP4063877B2 (de)
AT (1) ATE214284T1 (de)
AU (1) AU1381697A (de)
CA (1) CA2254791A1 (de)
DE (1) DE69619860T2 (de)
FR (1) FR2743075B1 (de)
WO (1) WO1997024133A1 (de)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2777190B1 (fr) * 1998-04-14 2001-07-27 Georges Camprasse Procede d'extraction, identification des principes actifs contenus dans la coquille interne et externe des mollusques marins, leur utilisation dans des preparations a visee thera peutique,diagnostic et cosmetique
GB9823307D0 (en) * 1998-10-23 1998-12-23 Regent Genus Organisms Interna Composition for traetment of periodontopathy and related diseases
FR2799125B1 (fr) * 1999-10-05 2002-01-18 Centre Nat Rech Scient Procede de preparation d'une composition par extraction de nacre, comprenant l'integralite des composants de la nacre, composition obtenue par ce procede et son utilisation en pharmacie et cosmetique.
FR2808657B1 (fr) * 2000-05-11 2003-06-13 Pharma Futura Composition commestible comprenant de la poudre de nacre micronisee
FR2827478B1 (fr) * 2001-07-18 2003-10-24 Jean Louis Montero Procede de preparation d'une poudre a base de nacre, proteine isolee de ladite poudre et leurs utilisations en chirurgie osseuse et dans diverses pathologies osteoarticulaires
FR2856303B1 (fr) * 2003-06-20 2007-09-07 Innovation Et De Rech Applique Utilisation therapeutique de lipides extraits de nacre
FR2863163B1 (fr) * 2003-12-04 2006-02-24 Oreal Composition, notamment cosmetique, comprenant des extraits de fougere et de nacre
FR2866238B1 (fr) * 2004-02-13 2006-12-15 Innovation Et De Rech Applique Liquides extrapalleaux de mollusques, obtention, formulation et utilisation
FR2899478A1 (fr) * 2006-04-05 2007-10-12 Innovation Et De Rech Applique Procede d'extraction de molecules de nacre, compositions et utilisation
CN100362912C (zh) * 2006-04-12 2008-01-23 中国科学院南海海洋研究所 一种红壳色品系马氏珠母贝的制种方法
FR2900343B1 (fr) * 2006-04-26 2008-07-04 Robert Wan Luxury Ltd Composition inhibitrice de proteases, notamment la papainee, la cathepsine k et la cathepsine b, et procede de purification de molecules inhibitrices de proteases
CA2566562A1 (en) * 2006-10-31 2008-01-24 Scallop Shell Pollution Solution Ltd. System and process for producing a cleaner containing shell extract and low-suspended solids
JP2010095464A (ja) * 2008-10-15 2010-04-30 Mikimoto Pharmaceut Co Ltd 皮膚外用剤およびその製造方法
FR2944214B1 (fr) * 2009-04-10 2012-04-27 Centre Nat Rech Scient Obtention et utilisation de principe actifs des calcaires
FR2946883B1 (fr) * 2009-06-22 2012-04-13 Newco Brevets Produit et procede pour ameliorer la fertilite des mammiferes
FR2949323B1 (fr) * 2009-08-28 2011-10-21 Newco Brevets Produit d'obturation et de traitement pour les canaux des racines dentaires
JP5679402B2 (ja) * 2010-02-08 2015-03-04 御木本製薬株式会社 皮膚角化促進剤
US8205623B2 (en) * 2010-04-05 2012-06-26 Rovcal, Inc. Coatings for personal grooming apparatus containing calcium carbonate derived from mollusk shells or pearls
CN104905242B (zh) * 2014-03-14 2017-06-13 浙江欧诗漫生物股份有限公司 一种从珍珠中分离制备珍珠可溶食用钙和珍珠复合美白因子溶液的方法
FR3037801B1 (fr) * 2015-06-23 2017-08-11 Jd Invest Materiau semi-synthetique pulverulent, obtenu par modification de la composition d'un biomateriau naturel marin, son procede de fabrication, ses applications

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2715568B1 (fr) * 1994-01-28 1996-04-12 Joseph Virassamy Utilisation de poudre de nacre pour prothèse et implants de prothèse conçus pour cela.

Also Published As

Publication number Publication date
DE69619860T2 (de) 2002-11-07
US6251438B1 (en) 2001-06-26
AU1381697A (en) 1997-07-28
EP0869805A1 (de) 1998-10-14
EP0869805B1 (de) 2002-03-13
JP2000504314A (ja) 2000-04-11
CA2254791A1 (fr) 1997-07-10
WO1997024133A1 (fr) 1997-07-10
FR2743075B1 (fr) 1998-03-27
JP4063877B2 (ja) 2008-03-19
ATE214284T1 (de) 2002-03-15
FR2743075A1 (fr) 1997-07-04

Similar Documents

Publication Publication Date Title
DE69619860D1 (de) Verfahren zur herstellung aktiver substanzen aus perlmutt, resultierende produkte, geeignet für medizinische anwendungen
FR2442054A1 (fr) Proteines purifiees, notamment interferon, procede de preparation et compositions pharmaceutiques les contenant
DE68907397D1 (de) Fluessige photopolymerisierbare zusammensetzung, viskoelastisches produkt, erhalten aus dieser zusammensetzung und verfahren zur herstellung dieses viskoelastischen produktes.
ATE116542T1 (de) Verfahren zur herstellung wirkstoffhaltiger mikropartikel aus hydrolytisch abbaubaren polymeren.
DE59601880D1 (de) Verfahren zur herstellung hydrophiler oder teilweise hydrophiler, anorganischer aerogele
DE69111175D1 (de) Verfahren zur Herstellung modifizierter proteinischer Produkte und Zusammensetzungen daraus.
ATE82495T1 (de) Verfahren zur herstellung pharmazeutischer mischungen.
DE59710059D1 (de) Verfahren zur herstellung fester pharmazeutischer formen durch extrudierung
DE3862873D1 (de) Verfahren zur herstellung von wasserabweisenden gegenstaenden aus gips und hydrophobierungsmittel enthaltende gipspulver.
DE59000270D1 (de) Verwendung von mindestens ein cytokin zur herstellung eines arzneimittels zur systemischen behandlung von praeneoplastischen laesionen.
DE3851830D1 (de) Verfahren zur Herstellung fester Formkörper aus Verbrennungsabfällen.
CA2413698A1 (en) Endoparasiticidal agents for voluntary oral ingestion by animals
ATE406870T1 (de) Filmförmige, zerfallsfähige zubereitungen zur wirkstoff-freisetzung und verfahren zu deren herstellung
ATE254922T1 (de) Pharmazeutische zusammensetzungen mit antimikrobieller wirkung
DE59008170D1 (de) Verfahren zur Herstellung mikronisierter bioabbaubarer Partikel.
ATE160588T1 (de) Aus bakteriellen proteinen bestehender extrakt, verfahren zur dessen herstellung und diesen extrakt enthaltende pharmazeutische zusammensetzung
ATE74487T1 (de) Verfahren zur herstellung und verwendung fester, pflanzenwirksamer zusammensetzungen.
DE68912682D1 (de) Geformter Körper aus Kunststein und Verfahren zu seiner Herstellung.
ATE246515T1 (de) Verfahren zur herstellung von oralen dosierungsformulierungen enthaltend diclofenac
DE3887068D1 (de) 2,2-Dimethylchromenderivate, Verfahren zur Herstellung und diese enthaltende pharmazeutische Zusammenstellungen.
ATE114300T1 (de) Verfahren zur herstellung von albuterol, sowie von arylglyoxal-, acetal-, hemiacetal- und hydrat-zwischenprodukten.
ATE96662T1 (de) Verwendung von c-20 bis c-26-aliphatischen alkoholen zur herstellung eines arzneimittels zur behandlung viraler infektionen.
KR980000100A (ko) 양식어류의 성장촉진을 위한 사료 첨가제 조성물
EP0402923A3 (de) Neue 2,5-Diaminotetraline, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
ATE25708T1 (de) Biologisch aktive konjugate, ihre herstellung und ihre anwendung.